Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.10 | -22.97 |
PEG Ratio (TTM) | 0.04 | 17.36 |
P/S Ratio (TTM) | 2.09 | 49.62 |
P/B Ratio (TTM) | 0.71 | 19.20 |
P/FCF Ratio (TTM) | -1.80 | 1.43 |
Price to 5YR AVG Earnings Ratio | -2.14 | -2.06 |
Price to 5YR AVG FCF Ratio | -2.94 | -7.44 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -29.12% | -4.06% |
ROE (TTM) | -31.11% | 21.29% |
Net Profit Margin (TTM) | -99.76% | -1,299.04% |
ROIC 5YR AVG | -2,057.26% | 17.41% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -81.96% | -57.78% | -64.18% |
Revenue | 153.79% | 1,843.21% | 1,420.60% |
Net Income | -80.94% | -95.65% | -87.41% |
Cash Flow | -48.68% | -429.75% | -8,155.79% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 7.27 | 6.01 |
Quick Ratio (TTM) | 7.27 | 5.73 |
D/E Ratio (TTM) | 0.01 | -17.30 |
Interest Coverage (TTM) | -25.42 | 1.23 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | 0.80 | 13.35 |
LTL to 5YR AVG FCF | -0.02 | 0.18 |
Shares Outstanding Growth 5YR AVG | 29.32% | 123.47% |